Home » Topics » BioWorld Science

BioWorld Science
RSS

HS6ST2 predicts survival in PDAC

Jan. 24, 2022

IM-1761065, a novel biguanide with promising activity in models of glioblastoma

Jan. 24, 2022

Oasmia advances its next-generation XR-18 drug delivery technology

Jan. 24, 2022

Engineered virus-like particles for in vivo delivery of gene editing proteins

Jan. 24, 2022

New approach integrates CAR-T cell immunotherapy with local activation of small-molecule prodrugs

Jan. 24, 2022

Inventisbio Shanghai discloses GTPase KRAS mutant inhibitors

Jan. 24, 2022

Shanghai Institute of Materia Medica identifies new S1PR1 agonists

Jan. 24, 2022

Immunophage Biomedical presents new CCR8 antagonists

Jan. 24, 2022

Sichuan Haisco Pharmaceutical discloses new JAK inhibitors

Jan. 24, 2022

Chinese researchers patent sigma-1 receptor agonists

Jan. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.